Fusion Antibodies PLC (FAB) — Free Cash Flow Generation Index

Latest as of March 2022: 0.61x

Fusion Antibodies PLC (FAB) has a Free Cash Flow Generation Index of 0.61x as of March 2022. Free cash flow of GBX107.00K represents 1% of operating cash flow (GBX174.00K). Explore FAB capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.61x

Free Cash Flow / Operating CF

Free Cash Flow

GBX107.00K

GBX

Operating Cash Flow

GBX174.00K

GBX

Capital Expenditures

GBX67.00K

GBX

Fusion Antibodies PLC Free Cash Flow Generation Index (2016–2018)

Historical FCF Generation Index trend for Fusion Antibodies PLC across 2 annual periods. For the full cash flow conversion analysis, see Fusion Antibodies PLC cash conversion from operations.

Annual Free Cash Flow Generation for Fusion Antibodies PLC (2016–2018)

Year-by-year Free Cash Flow Generation Index for Fusion Antibodies PLC. Check Fusion Antibodies PLC (FAB) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (GBX)	Operating CF	Capital Expenditures	YoY Change
2018	-4.76x	GBX-367.40K	GBX77.19K	GBX444.60K	▼ -630.7%
2016	0.90x	GBX310.81K	GBX346.57K	GBX35.76K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).